Proteína de suero de leche

Whey Protein: A Comprehensive Encyclopedic Reference

1. Identity, Nomenclature, and Natural Source

Whey protein is not a single molecule but a collective term for the family of globular proteins found in the liquid fraction of milk that remains after coagulation and removal of casein during cheesemaking. Chemically, it is classified under the broader category of milk proteins (Bovine lacto-serum proteins). The term "whey proteins" refers specifically to the milk proteins that remain soluble at pH 4.6 and at a temperature of 20°C.

The principal components of whey are β-lactoglobulin, α-lactalbumin, serum albumin, lactoferrin, immunoglobulins, lactose, and soluble mineral salts. The primary components of whey proteins include β-lactoglobulin (50–55%), α-lactalbumin (20–25%), immunoglobulins (10–15%), and bovine serum albumin (5–10%), along with minor proteins such as lactoferrin, lactoperoxidase, glycomacropeptide, protease-peptone, and osteopontin.

The ratio of whey proteins to casein is 1.5 for breast milk and 0.25 for cow milk; that is, 40% of human milk protein is casein and 60% lactalbumin, and cow milk is 80% casein and 20% lactalbumin. Whey proteins do not contain phosphorus, and remain in solution at low pH whereas casein proteins do not.

The primary natural source of commercial whey protein is bovine milk (Bos taurus). The milk-to-whey protein conversion begins with cheese production. While modern facilities now specifically process milk for whey protein, the traditional and still most common source is cheese manufacturing. The process begins when raw milk is pasteurized and standardized to the desired fat content; cheesemakers then add starter cultures and rennet to the milk, causing the milk to separate into two distinct parts: curds (the solid portion containing casein proteins and fat that become cheese) and whey (the liquid portion containing water, whey proteins, lactose, and minerals).

2. Commercial Forms and Preparations

The three main commercial types are whey protein concentrate (WPC), whey protein isolate (WPI), and whey protein hydrolysate (WPH), each varying in protein content, lactose, and fat levels.

• Whey Protein Concentrate (WPC): WPC is typically produced using membrane-based techniques such as ultrafiltration or microfiltration and contains 35–80% protein. WPC retains more of the natural nutrients found in whey, including immunoglobulins and lactoferrin, which support immune health.
• Whey Protein Isolate (WPI): WPI is the purest form of whey protein, containing over 90% protein and minimal fats and lactose. WPI is obtained through ion exchange chromatography or diafiltration, contains over 90% protein with minimal lactose and lipids.
• Whey Protein Hydrolysate (WPH): WPH is processed to break down the protein into smaller peptides, making it the fastest-absorbing form. During hydrolysis, enzymes partially break down the protein chains into smaller peptides, essentially pre-digesting the protein; the enzymatic breakdown process creates protein fragments that the digestive system can absorb more quickly and easily.

All three forms are typically delivered as dry powders, reconstituted in liquid for consumption, and also appear in ready-to-drink beverages, food bars, and clinical enteral nutrition products. Regardless of processing level, all types of whey protein contain the complete set of nine essential amino acids the body cannot produce on its own.

3. Traditional and Historical Use

Whey protein's origins can be traced back approximately 8,000 years to the inception of cheesemaking, with the earliest evidence of cheesemaking dating to 5,500 BC in Kujawy, Poland. During this time, people observed that when milk was treated with an acid, it formed a coagulated milk gel which could be processed into cheese; the remaining liquid by-product, known as whey, was either discarded, used as a starter culture for future cheese production, or utilised as feed for pigs.

Ancient civilizations recognized whey's value long before modern nutritional science. Hippocrates, the Greek physician often called the father of medicine, reportedly prescribed whey to his patients around 400 BC as a tonic for health and vitality. For thousands of years across Europe, whey was consumed as a health beverage, fed to livestock, and used in early folk medicine. In 18th-century Switzerland, "whey cures" at Alpine spas were fashionable among the wealthy; visitors would travel to mountain towns to drink fresh whey daily, believing it aided digestion, skin health, and general well-being.

Whey was also incorporated into specific traditional food products. Mozzarella and Ricotta are two Italian famous cheeses that use whey in the cheesemaking process; the name Ricotta means "recooked" and comes from the fact that the whey is reheated in the cheesemaking process. Whey can also be found in a number of other cheeses throughout Europe, ranging from the Norwegian Brunost, Mysost, or Gjetost cheeses to the Greek Monouri, Mizithra, and Anthotyros cheeses.

Historically, whey, being a byproduct of cheesemaking, was considered a waste product and was pumped into rivers and streams in the U.S. Since the whey contained protein, this practice led to the growth of large concentrations of algae, which were deemed a hazard to the ecosystem because they prevented sunlight and oxygen from reaching the water. The government eventually prohibited this practice, which led to a disposal problem for producers; their first solution was to use it as a cheap filler in the production of ice cream.

Historically whey was the liquid left over from cheese production that was often discarded or used as animal feed. In the 1970s, as nutritional science advanced, researchers began recognizing the exceptional nutritional profile of whey proteins. This discovery coincided with the growing fitness movement, creating the perfect conditions for whey protein to emerge as a valuable supplement.

4. Key Constituents and Active Compounds

4.1 Major Protein Fractions

β-Lactoglobulin is the dominant fraction, accounting for approximately 50–55% of total whey protein. It is not found in human milk, in contrast to bovine milk where it is the chief component. It is a globular protein capable of binding hydrophobic ligands and is a major allergen in cow's milk protein allergy.

α-Lactalbumin constitutes approximately 20–25% of whey protein. α-Lactalbumin has a high content of the amino acid tryptophan, a precursor of the vitamin niacin, making it an excellent source of niacin equivalents. Of whey proteins, α-lactalbumin typically constitutes about 40% by weight of the total human milk proteins.

Lactoferrin is a glycoprotein with iron-binding capacity present in minor quantities. Lactoferrin is a whey glycoprotein with antimicrobial properties that sequesters free iron.

Immunoglobulins constitute approximately 10–15% of whey proteins. Some studies have observed an increase in the percentage of immunoglobulin G after whey protein supplementation; IgG contained in whey proteins has a potential immune modulatory effect in humans.

4.2 Amino Acid Profile

Rich in essential amino acids, particularly branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine, whey protein provides the necessary building blocks for muscle protein synthesis (MPS). The high leucine content is of particular interest, as leucine has been identified as a key trigger for initiating MPS through the activation of specific cellular signaling pathways. Whey protein is characterized by its rich content of sulfur-containing amino acids and an advantageous ratio of essential amino acids, which has been shown to promote muscle protein synthesis and modulate lipid metabolism.

4.3 Bioactive Peptides

Whey protein has been purported to improve markers of metabolic and cardiovascular health via multiple mechanisms linked with the increased delivery of bioactive peptides, defined as the fragments of amino acid sequences in a protein that provide biological functions beyond their nutritional value. Notable bioactive peptides derived from whey include lactokinin and other ACE-inhibitory peptides, which are generated during digestion of β-lactoglobulin and α-lactalbumin.

4.4 Glutathione Precursors

The anti-carcinogenic qualities of whey protein have been associated with the sulphur amino acid cysteine, a substrate that combines with glutamate to form γ-glutamylcysteine; subsequently, glycine is combined to form the antioxidant glutathione, a strong xenobiotic metabolizer that protects against oxidative stress. Glutathione is an intracellular antioxidant for which whey's cysteine is a precursor.

5. Mechanisms of Action

5.1 Stimulation of Muscle Protein Synthesis via mTOR Pathway

Ingestion of leucine-enriched essential amino acid nutrients rapidly and potently activates the mammalian target of rapamycin (mTOR) signalling pathway and protein synthesis in human skeletal muscle; further, mTOR signalling and muscle protein synthesis are enhanced when leucine-enriched nutrients are ingested following resistance exercise.

The anabolic actions of leucine and insulin appear to activate independent intracellular signalling pathways which converge at mTOR and eventually affect translation initiation and elongation. Specifically, insulin activates phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB/Akt); Akt phosphorylates and inhibits tuberous sclerosis complex (TSC2), which relieves inhibition on Rheb (Ras homologue enriched in brain) and allows activation of mTOR.

Leucine activates the signalling factor mTOR to promote protein synthesis in skeletal muscle and in adipose tissue; it is also a major regulator of the mTOR-sensitive response of food intake to a high-protein diet.

Ingesting protein after resistance exercise significantly increases the phosphorylation of Akt and mTOR in a dose-dependent manner. These findings suggest that whey protein intake after resistance exercise activates mTOR signaling in a dose-dependent manner in untrained men.

5.2 Rapid Digestion and Amino Acid Availability

Whey protein, derived from milk, is a high-quality source of protein containing bioactive peptides and branched-chain amino acids which are rapidly digested and delivered to the small intestine intact. WP increases postprandial amino acid availability and stimulates protein synthesis rates. Whey proteins are generally fast-digesting compared to other protein sources like casein.

5.3 Glycemic and Insulin Modulation

Studies have reported whey protein ingestion to elicit improvements in postprandial glycemic and insulin control, which may be attributed to enhanced β-cell function leading to elevated levels of plasma glucagon-like peptide-1 (GLP-1).

5.4 Antioxidant and Immune Mechanisms

Preclinical research has demonstrated that whey protein can reduce oxidative stress in the tumor microenvironment, induce apoptosis via caspase-3/7 activation, and arrest the cell cycle in the G0/G1 phase. A high cysteine content enhances intracellular glutathione synthesis, thereby protecting against chemotherapy-induced toxicity.

Whey provides lactoferrin and immunoglobulins, components with antimicrobial properties. Its cysteine promotes the production of glutathione, an intracellular antioxidant. Lactoferrin, by binding free iron, can limit the growth of bacteria that depend on it.

6. Scientific Evidence by Area of Use

6.1 Skeletal Muscle Mass and Strength (Resistance Training Populations)

This is the most extensively studied application of whey protein supplementation. The process of muscle protein synthesis (MPS) plays a pivotal role in the enhancement of muscle function. Following a bout of exercise, the rate of MPS experiences an elevation for a brief period known as the "anabolic window," and whey protein supplementation has been demonstrated to augment this post-exercise anabolic window.

A systematic review and meta-analysis published in PMC in 2023 following PRISMA guidelines included 21 RCTs, with 15 studies subjected to meta-analysis, to evaluate the effects of whey protein supplementation on post-exercise MPS and its AKT/mTOR pathway in healthy adults. This and related work demonstrates the stimulatory effect of WPI supplementation on the activation of regulators of translational initiation, the key step in the commencement of cellular protein synthesis, following a single bout of resistance exercise; ingestion of WPI (26.6 g) immediately at the completion of exercise was effective.

A separate meta-analysis of eight studies containing 13 RCTs in young, healthy adults found that the high-quality evidence from the 13 RCTs was meta-analysed, yielding overall positive small-to-medium effects for whey protein from less than 24 to 96 hours (ES range = 0.4 to 0.7) for the temporal restoration of contractile function compared to the control treatment.

A 2019 PMC meta-analysis examined body composition specifically in resistance training practitioners: this review analyzed the impact of WP supplementation in its concentrated, hydrolyzed, and isolated forms, comparing it exclusively to isocaloric placebos, using random-effects meta-analyses from 246 healthy athletes undergoing 64.5 ± 15.3 days of training in eight RCTs.

Evidence strength: Moderate to strong for augmentation of muscle protein synthesis acutely. Effect sizes on long-term lean mass accrual are typically small-to-moderate, and results are more robust when combined with resistance training than in the absence of exercise.

6.2 Sarcopenia and Muscle Preservation in Older Adults

A systematic review and meta-analysis (PubMed, 2023) examined whey protein during resistance exercise training in older individuals with sarcopenia: seven randomized clinical trials (591 participants) were included, and five provided data for quantitative synthesis. The overall pooled SMD showed a small effect size in favour of resistance exercise training plus whey protein for skeletal muscle mass according to appendicular muscle index (SMD = 0.24; 95% CI, 0.05 to 0.42; p = 0.01; I² = 0%), and a significant difference of +2.31 kg in handgrip strength in the resistance exercise training plus whey protein group. However, the effect sizes were small, and the quality of the evidence was low to very low according to the GRADE approach.

A second meta-analysis (Clinical Nutrition, 2024) conducted searches up to June 2024 across PubMed, EMBASE, the Cochrane Library, and Scopus: the results indicate that whey protein supplementation can significantly increase the strength of the lower body when combined with resistance training, but does not appear to have a significant clinical effect on handgrip strength; the results of randomized clinical trials in this regard have been inconsistent.

A larger 2025 systematic review with pairwise meta-analysis (MDPI Healthcare) included 25 studies involving 1,454 participants with mean ages ranging from 64 to 84 years. Overall, compared with controls, WP supplementation increased lower-body muscular strength (SMD: 0.16; 95% CI: 0.04 to 0.28; p = 0.007; 19 trials), but without significantly changing upper-body muscular strength, body composition, or other cardiometabolic health markers. However, WP supplementation increased fasting insulin and homeostatic model assessment of insulin resistance.

Evidence strength: Moderate; benefits exist for lower-body strength in combination with resistance exercise, but effect sizes are small, and clinical meaningfulness of changes is uncertain. Evidence quality is generally rated low to very low by GRADE.

6.3 Body Composition and Weight Management

High-protein diets have been shown to achieve greater satiety, increased thermogenesis with resulting loss of fat mass, and better preservation of fat-free mass compared with normoproteic diets, especially when combined with physical activity. Protein is the most satiating macronutrient, with a linear relationship between the sensation of satiety and the amount consumed.

A meta-analysis published in Clinical Nutrition ESPEN that pooled 35 RCTs with 1,902 adult participants found that the effect of WP supplementation on BMI (−0.156, 95% CI: −0.31, 0.00, P < 0.05), body fat mass (−0.144, 95% CI: −0.28, 0.00, P < 0.05), and waist circumference (−0.448, 95% CI: −0.86, −0.03, P < 0.05) was statistically significant within groups.

It has been shown in some, but not all, studies that whey protein may regulate food intake and satiety, even in patients who underwent metabolic bariatric surgery, compared with other sources of protein.

A systematic review on whey protein in post-bariatric surgery patients found that whey protein may contribute to the maintenance of body weight and BMI by promoting fat-free mass preservation and reducing fat mass.

Evidence strength: Moderate. Whey protein can support modest improvements in body composition, particularly fat mass reduction and fat-free mass preservation during caloric restriction, but effect magnitudes are typically small and heterogeneity across studies is high.

6.4 Cardiometabolic Health (Lipids, Blood Pressure, Glycemic Control)

A 2024 systematic review and meta-analysis (Clinical Nutrition, 21 RCTs) conducted a systematic search of PubMed, Web of Science, Scopus, and Cochrane Library up to June 2024: whey protein supplementation may be an effective intervention for reducing LDL and total cholesterol levels, particularly in healthy, overweight/obese adults aged under 50 years, with the greatest benefits observed when combined with exercise; healthy adults also showed a benefit regarding triglyceride levels. Whey protein supplementation had no effect on HDL-cholesterol concentration but did elicit a reduction in LDL-cholesterol in individuals aged under 50 years and when combined with exercise (MD: −5.38, 95% CI: −8.87 to −1.88, I² = 0%, P < 0.01).

Total cholesterol was reduced with interventions that combined whey protein supplementation and exercise (MD: −8.58, −14.32 to −2.83, I² = 55%, P < 0.01), irrespective of age, protein dose, and body mass.

A separate meta-analysis (Clinical Nutrition, 2024) evaluating 63 RCTs on high-quality proteins found that whey supplementation decreased systolic blood pressure (−2.20 [−3.89, −0.51] mmHg), diastolic blood pressure (−1.07 [−1.98, −0.16] mmHg), and triglycerides (−0.10 [−0.17, −0.03]).

Regarding glycemic markers, HOMA-IR values were significantly lower in the milk protein supplement-treated group than untreated counterparts in short- and long-term supplementation (≤8 and >8 weeks) with high or moderate doses (≥60 or 30–60 g/d). Serum fasting blood glucose levels were considerably reduced upon short-term administration of a low daily dose of WP (<30 g). Furthermore, levels of serum fasting insulin were remarkably decreased during long-term supplementation with high or moderate daily doses of WP.

Evidence strength: Moderate for LDL cholesterol and blood pressure reduction, particularly when combined with exercise. Glycemic effects appear meaningful at moderate-to-high doses. Studies are generally short-term; long-term cardiovascular outcome data are lacking.

6.5 Immune Function and Cancer-Supportive Applications

The biological components of whey proteins have a large range of immune-enhancing properties and, moreover, there are studies of their ability to act not only as an antioxidant, but also as an antihypertensive, antitumor, hypolipidemic, antiviral, and antibacterial agent. Whey proteins have an iron-binding capacity that may contribute to their anticancer potential because of the mutagenic action of iron that can cause oxidative damage to tissues.

A double-blind RCT in cancer patients (42 participants aged 41–63 years undergoing intravenous chemotherapy in Thailand) found that patients received 40 g of WPI plus zinc and selenium (intervention group, n = 23) or a maltodextrin oral snack (control group, n = 19) daily for 12 weeks; whey protein supplementation significantly increased albumin (2.9%) and immunoglobulin G (4.8%) levels compared to the control group at week 12.

A systematic review of whey protein's anticancer potential (PMC, 2025) concluded that evidence drawn from both laboratory and clinical research suggests that whey proteins may exert anticancer effects by inhibiting tumor cell growth, promoting apoptosis, enhancing antioxidant defenses, modulating immune activity, and influencing signaling pathways. A randomized, placebo-controlled trial by Mazzuca et al. (2019) showed that daily supplementation with a purified WP formulation improved skeletal muscle mass and significantly reduced chemotherapy-related hematologic and gastrointestinal toxicities in CRC patients.

Whey contains bioactive components — lactoferrin, immunoglobulins, cysteine as a precursor of glutathione — that give it a reputation for immune support; in healthy, well-nourished people, however, the evidence for a direct benefit remains weak and largely indirect.

Extensive animal studies indicate the efficacy of whey protein against cancers and oxidative stress-induced tissue injury. Potential antioxidant and anticancer properties of WP are correlated with its ability to increase glutathione levels. Initial studies on WPC showed its benefit over other proteins such as soy and casein in reducing the incidence of colorectal cancer via glutathione elevation.

Evidence strength: Preliminary to moderate in cancer-supportive nutrition. Human trial evidence in clinical oncology populations is limited by small sample sizes. The majority of anticancer mechanistic evidence derives from animal and in vitro studies. Evidence for direct immune benefit in healthy individuals is weak and indirect.

7. Body Systems Associated with Whey Protein

• Musculoskeletal system: Primary and most robustly evidenced area; stimulates muscle protein synthesis, supports muscle mass, and aids recovery from resistance exercise.
• Cardiovascular system: Bioactive peptides (e.g., lactokinins) inhibit angiotensin-converting enzyme (ACE), contributing to modest blood pressure reduction; effects on LDL cholesterol and triglycerides documented in meta-analyses.
• Metabolic/endocrine system: Influences postprandial insulin response, GLP-1 secretion, and fasting glucose; potential role in insulin sensitivity management.
• Immune system: Lactoferrin, immunoglobulins, and cysteine-derived glutathione support immune defenses, though clinical magnitude in healthy adults is poorly demonstrated.
• Gastrointestinal system: Dietary protein intake impacts body composition, satiety, cognition, immune and cardiometabolic health. Gut microbiota effects have been reported, though findings are mixed.
• Oncology (supportive): Being investigated for preservation of lean mass, reduction of chemotherapy toxicity, and enhancement of antioxidant defenses in cancer patients.

8. Dosage Forms and Dosages Reported in Studies

Whey protein is commercially available primarily as a dry powder for reconstitution, but also appears in ready-to-drink liquid formats, bars, and clinical nutrition formulas. The following dosages are those reported specifically in cited clinical research:

• Doses of 20 grams of whey protein ingested either immediately prior to or following a single bout of resistant exercise have been previously reported to enhance the rate of protein synthesis.
• In one RCT, WPI was provided at 26.6 g, which provides 14% leucine and 26% BCAAs. This dose elicited a rapid rise in plasma amino acids, peaking around 1 hour following ingestion.
• In one mechanistic study, 15 male subjects performed four sets of six unilateral isokinetic concentric knee extensions; immediately after exercise, subjects consumed either water only or a 10 g (3.6 g EAA) or 20 g (7.1 g EAA) solution of whey protein in a randomized crossover design.
• In one double-blind RCT in cancer patients, subjects received 40 g of WPI plus zinc and selenium daily for 12 weeks.
• HOMA-IR values were significantly lower with high or moderate doses (≥60 or 30–60 g/d) of milk protein or whey protein in supplementation studies.
• Serum fasting blood glucose levels were considerably reduced upon short-term administration of a low daily dose of WP (<30 g).

Most sarcopenia and strength trials used doses in the range of 20–40 g per day, as reflected in their participant populations and protocols. The exact optimal dose varies by body weight, age, and the specific outcome being targeted, and no universal recommended dose has been established by a regulatory body.

9. Safety Considerations and Notable Interactions

9.1 General Safety Profile

There is an extremely low risk of renal (kidney) or liver damage related to whey protein supplementation in healthy individuals. Whey protein does not harm kidney function in healthy individuals consuming moderate amounts; however, those with existing kidney disease should limit protein intake, including whey, to avoid additional kidney stress.

9.2 Gastrointestinal Effects

Although whey protein supplement products are virtually lactose-free, small amounts of lactose may trigger digestive upset (abdominal pain, gas, and diarrhea) for participants who suffer from lactose intolerance. Whey provides no fiber to the diet, and excessive consumption may lead to constipation unless consumers consume high-fiber foods in addition to whey.

9.3 Allergy

Concerns have been raised about whether whey protein may elicit allergic responses or symptoms of lactose intolerance. Whey is a dairy-derived product, and individuals with confirmed cow's milk protein allergy may react to its consumption. β-Lactoglobulin is considered a primary cow's milk allergen.

9.4 Liver and Kidney Concerns in Vulnerable Populations

A narrative review revealed potential links between whey protein and liver and kidney damage, alterations in gut microbiota, increased acne incidence, impacts on bone mass, and emotional and behavioural changes. These findings underscore the complexity of whey protein's effects on human health, indicating both beneficial and detrimental outcomes in relation to different dosages. The review suggests caution for protein intake in situations of hepatic and renal compromised functions, as well as in acne susceptibility.

9.5 Insulin Resistance Signal in Older Adults

In a 2025 meta-analysis of older adults (25 studies, 1,454 participants), while WP supplementation increased lower-body muscular strength, WP supplementation increased fasting insulin and homeostatic model assessment of insulin resistance in this population, an effect requiring further investigation.

9.6 Acne

A narrative review reveals whey protein's potential link to increased acne incidence in some individuals. The proposed mechanism involves dairy-related hormonal signaling (e.g., IGF-1 stimulation), though the evidence from controlled clinical trials specifically for whey protein is limited.

9.7 Interactions

No well-characterized pharmacokinetic drug interactions with whey protein have been established in systematic clinical pharmacology studies as of current available evidence. The rapid digestive absorption of whey may theoretically affect the gastric absorption kinetics of co-administered oral medications, but this has not been systematically quantified in peer-reviewed clinical trials. Individuals with conditions requiring protein restriction (chronic kidney disease stage 3–5, advanced liver cirrhosis) should account for whey protein as part of total dietary protein intake under clinical supervision.

References

• ScienceDirect Topics — Whey Protein (Overview)
• PubMed Central — Effectiveness of Whey Protein Supplementation during Resistance Exercise Training on Skeletal Muscle Mass and Strength in Older People with Sarcopenia: A Systematic Review and Meta-Analysis (2023)
• Clinical Nutrition — Effectiveness of whey protein supplementation on muscle strength and physical performance of older adults: A systematic review and meta-analysis of randomized clinical trials (2024)
• PubMed — The effects of whey protein supplementation on indices of cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials (Clinical Nutrition, 2024)
• Clinical Nutrition — Effects of high-quality protein supplementation on cardiovascular risk factors in individuals with metabolic diseases: A systematic review and meta-analysis (2024)
• PubMed — The Effect of Whey Protein Supplementation on the Temporal Recovery of Muscle Function Following Resistance Training: A Systematic Review and Meta-Analysis (2018)
• PMC — Whey Protein Ingestion Activates mTOR-dependent Signalling after Resistance Exercise in Young Men: A Double-Blinded Randomized Controlled Trial
• PubMed — Whey protein intake after resistance exercise activates mTOR signaling in a dose-dependent manner in human skeletal muscle
• PMC — Leucine-Enriched Nutrients and the Regulation of mTOR Signalling and Human Skeletal Muscle Protein Synthesis
• PubMed — Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis
• PubMed — Leucine nutrition in animals and humans: mTOR signaling and beyond
• PMC — Comparative Meta-Analysis of the Effect of Concentrated, Hydrolyzed, and Isolated Whey Protein Supplementation on Body Composition of Physical Activity Practitioners
• Clinical Nutrition ESPEN — Effect of whey protein supplementation on weight and body composition indicators: A meta-analysis of randomized clinical trials
• PMC — Investigating the Health Implications of Whey Protein Consumption: A Narrative Review of Risks, Adverse Effects, and Associated Health Issues (2024)
• PMC — Clinical Impact of Highly Purified Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy
• PubMed — Whey Protein Supplementation Improves Nutritional Status, Glutathione Levels, and Immune Function in Cancer Patients: A Randomized, Double-Blind Controlled Trial
• PMC — Anticancer Potential of Whey Proteins—A Systematic Review of Bioactivity and Functional Mechanisms (2025)
• PMC — Use of Proteins as Biomarkers and Their Role in Carcinogenesis
• PMC — Effects of Whey Protein Supplementation on Body Composition, Muscular Strength, and Cardiometabolic Health in Older Adults: A Systematic Review with Pairwise Meta-Analysis (2025)
• PMC — Are Dietary Proteins the Key to Successful Body Weight Management? A Systematic Review and Meta-Analysis
• Nutrients (MDPI) — Effectiveness of Whey Protein Supplementation in Weight Loss Interventions for Patients with Obesity: A Systematic Review (2026)
• PMC — Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial
• PMC — Whey Protein Supplementation Combined with Exercise on Muscle Protein Synthesis and the AKT/mTOR Pathway in Healthy Adults: A Systematic Review and Meta-Analysis
• Wikipedia — Whey
• Natural Product Communications (SAGE) — Chemical Properties of Whey Protein in Protein Powders and Its Impact on Muscle Growth in Athletes: A Review (2025)